Annals of Surgical Oncology

, Volume 16, Issue 8, pp 2116–2122 | Cite as

Does Intraoperative Radiation Therapy Improve Local Tumor Control in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma? A Propensity Score Analysis

  • Timothy N. Showalter
  • Atul S. Rao
  • P. Rani Anne
  • Francis E. Rosato
  • Ernest L. Rosato
  • Jocelyn Andrel
  • Terry Hyslop
  • Xia Xu
  • Adam C. Berger
Hepatobiliary and Pancreatic Tumors



Locoregional recurrence (LRR) is an important factor after pancreaticoduodenectomy (PD) for pancreatic cancer. Intraoperative radiation therapy (IORT) administered to the resection bed may improve local tumor control.


We performed a retrospective analysis of patients who underwent PD at Thomas Jefferson University Hospital (TJUH) between 1995 and 2005 to identify patients who underwent resection with and without IORT. Data collected included age, gender, complications, margin status, stage, survival, and recurrence. Unadjusted analyses of the IORT and non-IORT groups were performed using Fisher’s chi-square method for discrete variables and Wilcoxon rank sum test for continuous variables. To account for biases in patient selection for IORT, a propensity score was calculated for each patient and adjusted statistical analyses were performed for survival and recurrence outcomes.


Between January 1995 and November 2005, 122 patients underwent PD for periampullary tumors, including 99 pancreatic cancers. Of this group, 37 patients were treated with IORT, and there was adequate follow-up information for a group of 46 patients who underwent PD without IORT. The IORT group contained a higher percentage of Stage IIB or higher tumors (65%) than in the non-IORT group (39.1%), though differences in stage did not reach significance (P = .16). There was a nonsignificant decrease in the rate of LRR in patients who had IORT (39% non-IORT vs. 23% IORT, P = .19). The median survival time of patients who received IORT was 19.2 months, which was not significantly different than patients managed without IORT, 21.0 months (P = .78). In the propensity analyses, IORT did not significantly influence survival or recurrence after PD.


IORT can be safely added to management approaches for resectable pancreatic cancer, with acceptable morbidity and mortality. IORT did not improve locoregional control and did not alter survival for patients with resected pancreatic cancer. IORT is an optional component of adjuvant chemoradiation for pancreatic cancer. In the future, IORT may be combined with novel therapeutic agents in the setting of a clinical trial in order to attempt to improve outcomes for patients with pancreatic cancer.


  1. 1.
    Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, et al. Resected adenocarcinoma of the pancreas–616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567–79.PubMedCrossRefGoogle Scholar
  2. 2.
    Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Ann Surg. 1992;217:144–8.Google Scholar
  3. 3.
    Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899–903.PubMedGoogle Scholar
  4. 4.
    Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection for pancreatic cancer. Cancer. 1987;59:2006–10.CrossRefGoogle Scholar
  5. 5.
    Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Stocken DD, Buchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH, et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer. 2005;92:1372–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Klinkenbijl JH, Jeekel H, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, et al. Adjuvant radiotherapy and 5-fluoruracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Ann Surg. 1999;230:776–84.PubMedCrossRefGoogle Scholar
  8. 8.
    Kennedy EP, Yeo CJ. The case for routine use of adjuvant therapy in pancreatic cancer. J Surg Oncol. 2007;95:597–603.PubMedCrossRefGoogle Scholar
  9. 9.
    Zuckerman DS, Ryan DP. Adjuvant therapy for pancreatic cancer: a review. Cancer. 2008;112:243–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Willett CG, Czito BG, Tyler DS. Intraoperative radiation therapy. J Clin Oncol. 2007;25:971–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Willett CG, Del Castillo CF, Shih HA, Goldberg S, Biggs P, Clark JW, et al. Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer. Ann Surg. 2005;241:295–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Ma H-B, Di Z-L, Wang X-J, Kang HF, Deng HC, Bai MH. Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic carcinoma. World J Gastroenterol. 2004;10:1669–71.PubMedGoogle Scholar
  13. 13.
    Mohiuddin M, Regine WF, Stevens J, Rosato F, Barbot D, Biermann W, et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol. 1995;13:2764–8.PubMedGoogle Scholar
  14. 14.
    Shipley WU, Wood WC, Tepper JE, Warshaw AL, Orlow EL, Kaufman SD, et al. Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma. Ann Surg. 1984;200:289–94.PubMedCrossRefGoogle Scholar
  15. 15.
    Tepper JE, Noyes D, Krall JM, Sause WT, Wolkov HB, Dobelbower RR, et al. Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Int J Radiat Oncol Biol Phys. 1991;21:1145–9.PubMedGoogle Scholar
  16. 16.
    Tuckson WB, Goldson AL, Ashayeri E, Halyard-Richarson M, DeWitty RL, Leffall LD Jr. Intraoperative radiotherapy for patients with carcinoma of the pancreas: the Howard University hospital experience, 1978–1986. Ann Surg. 1988;207:648–53.PubMedCrossRefGoogle Scholar
  17. 17.
    Valentini V, Balducci M, Tortoreto F, Morgani AG, De Giorgi U, Fiorentini G. Intraoperative radiotherapy: current thinking. EJSO. 2002;28:180–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Willett CG, Warshaw AL. Intraoperatic electron beam irradiation in pancreatic cancer. Frontiers in Bioscience. 1998;3:e207–13.PubMedGoogle Scholar
  19. 19.
    Zerbi A, Fossati V, Parolini D, Carlucci M, Balzano G, Bordogna G, et al. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer. 1994;73:2930–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Sindelar WF, Kinsella TJ. Studies of intraoperative radiotherapy in carcinoma of the pancreas. Ann Oncol. 1999;10:S226–30.CrossRefGoogle Scholar
  21. 21.
    Alfieri S, Morganti AG, Di Giorgio A, Valentini V, Bossola M, Trodella L, et al. Improved survival and local control after intraoperative radiation therapy and postoperative radiotherapy: a multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer. Arch Surg. 2001;136:343–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Farrell TJ, Barbot DJ, Rosato FE. Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer. Ann Surg. 1997;226:66–9.PubMedCrossRefGoogle Scholar
  23. 23.
    D’Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.PubMedCrossRefGoogle Scholar
  24. 24.
    Schwarz RE, Smith DD, Keny H, Ikle DN, Shibata SI, Chu DZ, et al. Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysis. Am J Clin Oncol. 2003;26:16–21.PubMedCrossRefGoogle Scholar
  25. 25.
    Hazard L, Tward JD, Szabo A, Shrieve DC. Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry data. Cancer. 2007;110:2191–201.PubMedCrossRefGoogle Scholar
  26. 26.
    Reni M, Panucci MG, Ferreri AJM, Balzano G, Passoni P, Cattaneo GM, et al. Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2001;50:651–8.PubMedGoogle Scholar
  27. 27.
    Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10:511–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Kokubo M, Nishimura Y, Shibamoto Y, Sasai K, Kanamori S, Hosotani R, et al. Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer. Int J Radiat Oncol Biol Phys. 2000;48:1081–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Nishimura Y, Hosotani R, Shibamoto Y, Kokubo M, Kanamori S, Sasai K, et al. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications. Int J Radiat Oncol Biol Phys. 1997;39:39–49.PubMedGoogle Scholar
  30. 30.
    Newman EA, Simeone DM, Mulholland MW. Adjuvant treatment strategies for pancreatic cancer. J Gastrointest Surg. 2006;10:916–26.PubMedCrossRefGoogle Scholar
  31. 31.
    Regine WF, Winter K, Abrams RA, Safran H, Hoffman JP, Konski A, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008;299:1019–26.PubMedCrossRefGoogle Scholar
  32. 32.
    Shimizu Y, Yasui K, Fuwa N, Arai Y, Yamao K. Late complication in patients undergoing pancreatic resection with intraoperative radiation therapy: gastrointestinal bleeding with occlusion of the portal system. J Gastroenterol Hepatol. 2005;20:1235–40.PubMedCrossRefGoogle Scholar
  33. 33.
    Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997;15:928–37.PubMedGoogle Scholar
  34. 34.
    Coquard R, Ayzac L, Gilly F-N, Romestaing P, Ardiet JM, Sondaz C, et al. Intraoperative radiotherapy in resected pancreatic cancer: feasibility and results. Radiother Oncol. 1997;44:271–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Dobelbower RR, Merrick HW, Khuder S, Battle JA, Herron LM, Pawlicki T. Adjuvant radiation therapy for pancreatic cancer: A 15-year experience. Int J Radiat Oncol Biol Phys. 1997;39:31–7.PubMedGoogle Scholar
  36. 36.
    Evans DB, Termuhlen PM, Byrd DR, Ames FC, Ochran TG, Rich TA. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg. 1993;218:54–60.PubMedCrossRefGoogle Scholar
  37. 37.
    O’Connor JK, Sause WT, Hazard LJ, Belnap LP, Noyes RD. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma. Int J Radiat Oncol Biol Phys. 2005;63:1060–6.PubMedGoogle Scholar
  38. 38.
    Kinsella TJ, Sindelar WF. Intraoperative radiotherapy for pancreatic carcinoma. Experimental and clinical studies. Cancer. 1996;78:598–604.PubMedGoogle Scholar
  39. 39.
    Sindelar WF, Kinsella TJ, Tepper JE, Travis EL, Rosenberg SA, Glatstein E. Experimental and clinical studies with intraoperative radiotherapy. Surg Gynecol Obstet. 1983;157:205–19.PubMedGoogle Scholar
  40. 40.
    Regine WF, Abrams RA. Adjuvant therapy for pancreatic cancer: current status, future directions. Semin Oncol. 2006;33:S10–S13.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  • Timothy N. Showalter
    • 1
  • Atul S. Rao
    • 3
  • P. Rani Anne
    • 1
  • Francis E. Rosato
    • 3
  • Ernest L. Rosato
    • 3
  • Jocelyn Andrel
    • 2
  • Terry Hyslop
    • 2
  • Xia Xu
    • 1
  • Adam C. Berger
    • 3
  1. 1.Department of Radiation OncologyThomas Jefferson UniversityPhiladelphiaUSA
  2. 2.Division of BiostatisticsThomas Jefferson UniversityPhiladelphiaUSA
  3. 3.Department of SurgeryThomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations